Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects

被引：0
作者：
Wenjia Zhou
Chengzhe Lv
Quanying Zhang
Shunlin Zong
Meng Wang
机构：
[1] The Second Affiliated Hospital of Soochow University,Clinical Pharmacology Laboratory
[2] Children’s Hospital of Soochow University,Department of Pharmaceutics
来源：
Clinical Drug Investigation | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：125 / 133
页数：8
相关论文
共 107 条
  • [1] Clarke CE(2007)Parkinson’s disease BMJ. 335 441-445
  • [2] Connolly BS(2014)Pharmacological treatment of Parkinson disease: a review JAMA. 311 1670-1683
  • [3] Lang AE(2014)Parkinson’s disease: a review Front Biosci. 6 65-74
  • [4] Beitz JM(2005)Alternatives to levodopa in the initial treatment of early Parkinson’s disease Drugs Aging. 22 731-740
  • [5] Lees A(2000)Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts Neurology. 54 S21-S23
  • [6] de Rijk MC(1997)Epidemiology of Parkinson’s disease Parkinsonism Relat Disord. 3 175-186
  • [7] Launer LJ(2005)Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai Lancet. 365 595-597
  • [8] Berger K(2006)Epidemiology of Parkinson’s disease Lancet Neurol. 5 525-535
  • [9] Breteler MM(2017)Parkinson’s disease: from pathogenesis to pharmacogenomics Int J Mol Sci. 18 E551-2476
  • [10] Dartigues JF(2008)Levodopa for the treatment of Parkinson’s disease N Engl J Med. 359 2468-66
12345678910